Akebia Therapeutics, Inc. (AKBA)
NASDAQ
$1.28-4.48%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 2,923,055
- 52-week high
- —
- 52-week low
- —
- Open
- $1.32
- Day high
- $1.38
- Day low
- $1.26
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $236.2M | -$5.35M | -$0.02 |
| 2024 | $160.18M | -$69.41M | -$0.33 |
| 2023 | $194.62M | -$51.93M | -$0.28 |
| 2022 | $292.48M | -$94.23M | -$0.52 |
| 2021 | $211.65M | -$282.02M | -$1.70 |
About Akebia Therapeutics, Inc.
A company overview for Akebia Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Akebia Therapeutics, Inc.'s stock price today?
- AKBA is trading at $1.28 as of Jul 20, 2026.
- Does Akebia Therapeutics, Inc. pay a dividend?
- Akebia Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.